203 related articles for article (PubMed ID: 28455524)
1. Mechanisms underlying cognitive deficits in a mouse model for Costello Syndrome are distinct from other RASopathy mouse models.
Schreiber J; Grimbergen LA; Overwater I; Vaart TV; Stedehouder J; Schuhmacher AJ; Guerra C; Kushner SA; Jaarsma D; Elgersma Y
Sci Rep; 2017 Apr; 7(1):1256. PubMed ID: 28455524
[TBL] [Abstract][Full Text] [Related]
2. An attenuated phenotype of Costello syndrome in three unrelated individuals with a HRAS c.179G>A (p.Gly60Asp) mutation correlates with uncommon functional consequences.
Gripp KW; Sol-Church K; Smpokou P; Graham GE; Stevenson DA; Hanson H; Viskochil DH; Baker LC; Russo B; Gardner N; Stabley DL; Kolbe V; Rosenberger G
Am J Med Genet A; 2015 Sep; 167A(9):2085-97. PubMed ID: 25914166
[TBL] [Abstract][Full Text] [Related]
3. Costello syndrome: a Ras/mitogen activated protein kinase pathway syndrome (rasopathy) resulting from HRAS germline mutations.
Gripp KW; Lin AE
Genet Med; 2012 Mar; 14(3):285-92. PubMed ID: 22261753
[TBL] [Abstract][Full Text] [Related]
4. HRAS germline mutations impair LKB1/AMPK signaling and mitochondrial homeostasis in Costello syndrome models.
Dard L; Hubert C; Esteves P; Blanchard W; Bou About G; Baldasseroni L; Dumon E; Angelini C; Delourme M; Guyonnet-Dupérat V; Claverol S; Fontenille L; Kissa K; Séguéla PE; Thambo JB; Nicolas L; Herault Y; Bellance N; Dias Amoedo N; Magdinier F; Sorg T; Lacombe D; Rossignol R
J Clin Invest; 2022 Apr; 132(8):. PubMed ID: 35230976
[TBL] [Abstract][Full Text] [Related]
5. Functional analysis of a duplication (p.E63_D69dup) in the switch II region of HRAS: new aspects of the molecular pathogenesis underlying Costello syndrome.
Lorenz S; Lissewski C; Simsek-Kiper PO; Alanay Y; Boduroglu K; Zenker M; Rosenberger G
Hum Mol Genet; 2013 Apr; 22(8):1643-53. PubMed ID: 23335589
[TBL] [Abstract][Full Text] [Related]
6. MEK-inhibitor-mediated rescue of skeletal myopathy caused by activating Hras mutation in a Costello syndrome mouse model.
Tidyman WE; Goodwin AF; Maeda Y; Klein OD; Rauen KA
Dis Model Mech; 2022 Feb; 15(2):. PubMed ID: 34553752
[TBL] [Abstract][Full Text] [Related]
7. Increased osteoclastogenesis contributes to bone loss in the Costello syndrome
Nandi S; Chennappan S; Andrasch Y; Fidan M; Engler M; Ahmad M; Tuckermann JP; Zenker M; Cirstea IC
Front Cell Dev Biol; 2022; 10():1000575. PubMed ID: 36330334
[TBL] [Abstract][Full Text] [Related]
8. Studying Metabolic Abnormalities in the Costello Syndrome HRAS G12V Mouse Model: Isolation of Mouse Embryonic Fibroblasts and Their In Vitro Adipocyte Differentiation.
Fidan M; Chennappan S; Cirstea IC
Methods Mol Biol; 2021; 2262():397-409. PubMed ID: 33977491
[TBL] [Abstract][Full Text] [Related]
9. Kinetic mechanisms of mutation-dependent Harvey Ras activation and their relevance for the development of Costello syndrome.
Wey M; Lee J; Jeong SS; Kim J; Heo J
Biochemistry; 2013 Nov; 52(47):8465-79. PubMed ID: 24224811
[TBL] [Abstract][Full Text] [Related]
10. HRAS mutants identified in Costello syndrome patients can induce cellular senescence: possible implications for the pathogenesis of Costello syndrome.
Niihori T; Aoki Y; Okamoto N; Kurosawa K; Ohashi H; Mizuno S; Kawame H; Inazawa J; Ohura T; Arai H; Nabatame S; Kikuchi K; Kuroki Y; Miura M; Tanaka T; Ohtake A; Omori I; Ihara K; Mabe H; Watanabe K; Niijima S; Okano E; Numabe H; Matsubara Y
J Hum Genet; 2011 Oct; 56(10):707-15. PubMed ID: 21850009
[TBL] [Abstract][Full Text] [Related]
11. Severe Intellectual Disability and Enhanced Gamma-Aminobutyric Acidergic Synaptogenesis in a Novel Model of Rare RASopathies.
Papale A; d'Isa R; Menna E; Cerovic M; Solari N; Hardingham N; Cambiaghi M; Cursi M; Barbacid M; Leocani L; Fasano S; Matteoli M; Brambilla R
Biol Psychiatry; 2017 Feb; 81(3):179-192. PubMed ID: 27587266
[TBL] [Abstract][Full Text] [Related]
12. C4ST-1/CHST11-controlled chondroitin sulfation interferes with oncogenic HRAS signaling in Costello syndrome.
Klüppel M; Samavarchi-Tehrani P; Liu K; Wrana JL; Hinek A
Eur J Hum Genet; 2012 Aug; 20(8):870-7. PubMed ID: 22317973
[TBL] [Abstract][Full Text] [Related]
13. A very mild phenotype in six individuals of a three-generation family with the novel HRAS variant c.176C > G p.(Ala59Gly): Emergence of a new HRAS-related RASopathy distinct from Costello syndrome.
Frey T; Ivanovski I; Bahr A; Zweier M; Laube J; Luchsinger I; Steindl K; Rauch A
Am J Med Genet A; 2023 Aug; 191(8):2074-2082. PubMed ID: 37194190
[TBL] [Abstract][Full Text] [Related]
14. Duplication of Glu37 in the switch I region of HRAS impairs effector/GAP binding and underlies Costello syndrome by promoting enhanced growth factor-dependent MAPK and AKT activation.
Gremer L; De Luca A; Merbitz-Zahradnik T; Dallapiccola B; Morlot S; Tartaglia M; Kutsche K; Ahmadian MR; Rosenberger G
Hum Mol Genet; 2010 Mar; 19(5):790-802. PubMed ID: 19995790
[TBL] [Abstract][Full Text] [Related]
15. Costello syndrome model mice with a Hras
Katata Y; Inoue SI; Asao A; Kobayashi S; Terui H; Inoue-Shibui A; Abe T; Niihori T; Aiba S; Ishii N; Kure S; Aoki Y
Cell Death Dis; 2020 Aug; 11(8):617. PubMed ID: 32792500
[TBL] [Abstract][Full Text] [Related]
16. Neurocognitive, adaptive, and behavioral functioning of individuals with Costello syndrome: a review.
Axelrad ME; Schwartz DD; Katzenstein JM; Hopkins E; Gripp KW
Am J Med Genet C Semin Med Genet; 2011 May; 157C(2):115-22. PubMed ID: 21495179
[TBL] [Abstract][Full Text] [Related]
17. Nonreentrant atrial tachycardia occurs independently of hypertrophic cardiomyopathy in RASopathy patients.
Levin MD; Saitta SC; Gripp KW; Wenger TL; Ganesh J; Kalish JM; Epstein MR; Smith R; Czosek RJ; Ware SM; Goldenberg P; Myers A; Chatfield KC; Gillespie MJ; Zackai EH; Lin AE
Am J Med Genet A; 2018 Aug; 176(8):1711-1722. PubMed ID: 30055033
[TBL] [Abstract][Full Text] [Related]
18. Oligodendrocyte RasG12V expressed in its endogenous locus disrupts myelin structure through increased MAPK, nitric oxide, and notch signaling.
Titus HE; López-Juárez A; Silbak SH; Rizvi TA; Bogard M; Ratner N
Glia; 2017 Dec; 65(12):1990-2002. PubMed ID: 28856719
[TBL] [Abstract][Full Text] [Related]
19. Abnormal Ras signaling in Costello syndrome (CS) negatively regulates enamel formation.
Goodwin AF; Tidyman WE; Jheon AH; Sharir A; Zheng X; Charles C; Fagin JA; McMahon M; Diekwisch TG; Ganss B; Rauen KA; Klein OD
Hum Mol Genet; 2014 Feb; 23(3):682-92. PubMed ID: 24057668
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic spectrum of Costello syndrome individuals harboring the rare HRAS mutation p.Gly13Asp.
Bertola D; Buscarilli M; Stabley DL; Baker L; Doyle D; Bartholomew DW; Sol-Church K; Gripp KW
Am J Med Genet A; 2017 May; 173(5):1309-1318. PubMed ID: 28371260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
